RANI Rani Therapeutics Holdings Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: RANI

Price (delayed)

$0.767

Market cap

$106.92M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.15

Enterprise value

$105.6M

?
Relative Growth: Rel. Growth: 59
Relative Strength: Rel. Strength: 43
Relative Valuation: Rel. Valuation: 5
Relative Profitability: Rel. Profitability: 28
Highlights
The EPS has soared by 84% YoY and by 48% from the previous quarter
The debt has dropped by 84% year-on-year and by 10% since the previous quarter
The net income has contracted by 2.4% from the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: https://www.ranitherapeutics.com
Peers: OLMA OMER VIVS ORIC

Key stats

What are the main financial stats of RANI

RANI stock price

How has the Rani Therapeutics Holdings stock price performed over time
Intraday
-1.4%
1 week
1.46%
1 month
-12.84%
1 year
59.76%
YTD
-43.19%
QTD
0.87%

Financial performance

How have Rani Therapeutics Holdings's revenue and profit performed over time
Revenue
$4.88M
Gross profit
$4.88M
Operating income
-$32.96M
Net income
-$30.14M
Gross margin
100%
Net margin
-618%
The operating margin has surged by 84% year-on-year and by 38% since the previous quarter
The net margin has surged by 75% year-on-year and by 33% since the previous quarter
RANI's gross profit has surged by 54% since the previous quarter
The revenue has soared by 54% from the previous quarter

Price vs fundamentals

How does RANI's price correlate with its fundamentals

Growth

What is Rani Therapeutics Holdings's growth rate over time

Valuation

What is Rani Therapeutics Holdings stock price valuation
P/E
N/A
P/B
2.42
P/S
29.44
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
21.65
The EPS has soared by 84% YoY and by 48% from the previous quarter
RANI's P/B is 85% below its 5-year quarterly average of 16.9
The company's equity rose by 38% QoQ
The revenue has soared by 54% from the previous quarter
RANI's P/S is 18% below its last 4 quarters average of 36.2

Efficiency

How efficient is Rani Therapeutics Holdings business performance
The ROS has soared by 72% YoY and by 31% from the previous quarter
Rani Therapeutics Holdings's return on equity has increased by 47% QoQ
The ROA has grown by 32% YoY and by 22% from the previous quarter
RANI's ROIC is up by 31% from the previous quarter but it is down by 19% YoY

Dividends

What is RANI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for RANI.

Financial health

How did Rani Therapeutics Holdings financials performed over time
The quick ratio has surged by 59% since the previous quarter
The current ratio has soared by 56% QoQ
The debt is 91% smaller than the equity
The company's debt to equity has surged by 102% YoY but it fell by 36% QoQ
The debt has dropped by 84% year-on-year and by 10% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.